SARS-CoV-2 Infection during Pregnancy in a Rural Midwest All-delivery Cohort and Associated Maternal and Neonatal Outcomes.
Haley A SteffenSamantha R SwartzJ Brooks JacksonKimberly A KennePatrick P Ten EyckAbbey S MerrymanClaire N CastanedaKatharine MarsdenTimothy MaxwellAnna E MerrillMatthew D KrasowskiMary B RysavyPublished in: American journal of perinatology (2021)
· SARS-CoV-2 seroprevalence rate in pregnant population in Iowa is 5.8%.. · Infections are higher among minorities, non-English speakers, and patients without private insurance.. · No increased adverse maternal/neonatal outcomes observed for SARS-CoV-2 infected mothers..